<DOC>
	<DOC>NCT01072591</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of a single intravenous dose of MEDI-578, a monoclonal antibody, in patients with osteoarthritis of the knee. It will also be evaluated how MEDI-578 is absorbed and distributed through the body.</brief_summary>
	<brief_title>Study to Assess MEDI -578 in Patients With Osteoarthritis (OA) of the Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patients with painful osteoarthritis of the knee. The pain from the knee must exceed pain experienced from any other condition. Patients must be willing and able to discontinue all current analgesic treatment. Any other form of arthritis than osteoarthritis. Presence of neuropathic pain, or fibromyalgia, or wide spread chronic pain not related to osteoarthritis. Significant abnormalities on the clinical examination that may interfere with the study or present a safety risk to the patient, as judged by the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>anti-NGF</keyword>
	<keyword>OA</keyword>
	<keyword>pain</keyword>
</DOC>